Inhibition of PLA2 signaling may represent an important signaling pathway to target for the treatment of Alzheimer's disease, to reduce the amount of APP that is released from neurons and decrease the burden of accumulation of toxic amyloid plaques. Here, APP is linked to Alzheimer disease.